Czech Republic - Cardiaca - Cardiaca 14 - Landiolol

This Czech public tender concerns the supply of medicinal products for parenteral administration containing the active substance landiolol (ATC code C07AB14). The products are intended for the treatment of patients in the approved indications as set out in the Summary of Product Characteristics valid on the date of submission of the offer. The buyer is located in the Czech Republic, although the specific contracting authority is not named in the available information. No estimated contract value, submission deadline, or detailed description of the procurement procedure is provided in the source text. Suppliers of pharmaceuticals wishing to bid should consult the official tender documentation for further details on requirements and timelines.

Description

33 open tenders right now

• Czech Republic - Echocardiograph - Echocardiographs for the Cardiology Clinic 21 Sep 2026 · 1 day left
• Antidiabetics - Insulins and combinations XI - Tresiba 21 Sep 2026 · 1 day left
• Czech Republic - Immunoglobulins - SCIG Immunoglobulins VI. - HYQVIA 22 Sep 2026 · 2 days left

Recent awards

• Česko - Léčivé přípravky pro zažívací trakt a metabolismus - Inhibitory protonové pumpy - Pantoprazol i.v. aplikace II.

  awarded to PROMEDICA PRAHA GROUP, a.s. €111,075

• Czech Republic - Gases - DNS - Gas supplies - 9th minitender - Supply of other and technical gases in pressure cylinders including accessories

  awarded to SIAD Czech spol. s r.o. €49,366

• Česko - Imunosupresiva - Selektivní imunosupresiva - inhibitory Janus kináz II. - Upadacitinib

  awarded to AbbVie s.r.o. €2,920,849

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€9,281,286

11,575 open across Europe right now 82% below sector average

Buyer track record on Aperlena

352 notices tracked · 167 awarded

€288,864,601 in awarded contracts